Neil Harris Cohen sold $6,516 of CMMB
director at Chemomab Therapeutics Ltd.. 2,304 shares at an average of $2.83, traded Aug 27, 2026, filed Sep 1, 2026.
Score components
- +15RoleDirector
- 0Trade size$7k at market
- 0Share of holdings soldSold 6.5% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001178913-26-004371, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Aug 27, 2026 | SOpen-market sale American Depositary Shares | -1,304 | $2.85 | $3,716 | 34,000 | 42 d ago |
| Aug 28, 2026 | SOpen-market sale American Depositary Shares | -1,000 | $2.80 | $2,800 | 33,000 | 42 d ago |
| Jul 16, 2020 | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +172 | $0.00 | $0 | 172 | 42 d ago |
| Apr 19, 2021 | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +2,971 | $0.00 | $0 | 3,143 | 42 d ago |
| Mar 7, 2022 | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +1,705 | $0.00 | $0 | 4,848 | 42 d ago |
| Mar 21, 2023 | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +1,714 | $0.00 | $0 | 6,562 | 42 d ago |
| Mar 18, 2024 | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +2,520 | $0.00 | $0 | 9,082 | 42 d ago |
| Mar 16, 2025 | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +3,821 | $0.00 | $0 | 12,903 | 42 d ago |
| Mar 16, 2026 | AGrant or award Stock option (right to buy American Depositary Shares)derivative | +5,172 | $0.00 | $0 | 18,075 | 42 d ago |
Related signals
Other insiders at Chemomab Therapeutics Ltd. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 36Weak | CMMBbuy Chemomab Therapeutics Ltd. | George Adi Mor Chief Executive Officer | $20k 9,804 shares | +8% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.